Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
about
P1343
Emergence of the Middle East respiratory syndrome coronavirusTIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserineMolecular advances in the cell biology of SARS-CoV and current disease prevention strategiesT-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria MarburgvirusA transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entryCD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirusDipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMCDistinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virusTMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike proteinSevere acute respiratory syndrome coronavirus-like virus in Chinese horseshoe batsACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGNGenetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratHuman coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell linesThe role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesisIdentification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virusImmunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificityRespiratory viruses other than influenza virus: impact and therapeutic advancesMolecular mechanisms of severe acute respiratory syndrome (SARS)Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseasesChloroquine is a potent inhibitor of SARS coronavirus infection and spread.A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterizationDesign of wide-spectrum inhibitors targeting coronavirus main proteasesMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlAnimal models for SARS and MERS coronavirusesReceptor-binding domain-based subunit vaccines against MERS-CoVHuman coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategiesCurrent advancements and potential strategies in the development of MERS-CoV vaccinesPhosphatidylserine receptors: enhancers of enveloped virus entry and infectionMechanisms of coronavirus cell entry mediated by the viral spike proteinConformational reorganization of the SARS coronavirus spike following receptor binding: implications for membrane fusionLack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret modelEzrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stageThe murine coronavirus hemagglutinin-esterase receptor-binding site: a major shift in ligand specificity through modest changes in architectureDecoding protein networks during virus entry by quantitative proteomicsHost-Species Transferrin Receptor 1 Orthologs Are Cellular Receptors for Nonpathogenic New World Clade B ArenavirusesA new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoMonoclonal antibody-based therapies for microbial diseasesRibonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein
P2860
Q21131373-099BE2B5-A1E5-47CE-9ECC-17BAE6B999D7Q21131381-B51FEA9D-2441-40D3-AD7A-01F1CE968162Q21245141-50033359-024A-4D59-9DE8-449768255482Q24301153-04974576-6D55-44D4-9E48-074618AD369EQ24306622-BCDD0FAB-F059-4BDF-B66C-784C052DBB8FQ24307914-A98FA238-DCBF-44EE-B8A9-C76FBAC1B3F8Q24329089-14D3C0E9-77AF-4C1C-ACBD-0E02ABD179D2Q24337838-0BAB12B3-7461-4D40-BCC4-9351118E0441Q24339582-4CB61F67-7570-48C9-ABF4-7DEAE832F2F2Q24536078-B1E1221D-5349-4C3C-AB95-8BC880D85F29Q24538811-76A36F2B-3F55-4F2A-B4A9-893D8EC832E3Q24563490-D8FFE285-5AC7-44F1-8B35-5D527640D66FQ24596042-665DA647-DA23-46CD-8CA8-2BB650A7DC16Q24600523-A774860C-E730-4DA2-867A-F1703A49BFA3Q24605877-BE33FB9D-789C-4E2E-B58E-5AE5D987D4BFQ24635006-C8EC5C29-5795-40E3-B394-F0A974DC7322Q24646829-810244BF-BE4E-45AB-9786-F56FD6F27C16Q24655957-050678EA-BFC2-4752-AEA7-58439A89CDF6Q24799739-07452E43-B89B-4DA1-A56C-304A0767F4D0Q24814157-FB95965F-0160-4B7D-845C-4453A8211C24Q24815979-E86EEF85-B84B-42F4-B1B7-057BD0FE65D3Q24816925-3328FD30-1E11-43E0-955B-494D35F0E3A2Q24817089-2A165A66-426E-42DD-9C18-F3ED7ED1665CQ24817106-9D4387E6-E40D-4526-9064-BBC3F7E39D84Q26796501-FF287CCA-8F4F-420C-8C69-AA2E23096006Q26799857-FE92DDD9-65A3-4E35-AE24-F6E7A2C3D59DQ26851979-8A3134D5-5B13-4C34-9F5F-73042B7F4A2AQ27011643-9433A4E3-6C96-452A-8CE9-A11E9F4F2CFFQ27012578-D564926A-E0F2-4885-9DFB-13A0500E0906Q27015034-03DC3195-716F-4F72-917F-755F4652CCC0Q27027678-1A215664-E962-4F31-A212-C36043A88B9CQ27302420-FFAF5C23-0193-4086-8405-8C6744C0008FQ27317179-F0D086CE-BF20-40F5-9219-4EFF510260D1Q27335547-47A3FAFB-A3D8-4863-9FD8-6CD1A7DA5BE9Q27347735-B4CCF32D-16D2-4D75-9021-A18BBC37909CQ27469058-9B98DF14-0C37-4F60-ACA9-824A26C9603CQ27488235-93683640-5D82-4947-B60C-B41C58704DF8Q27490484-D012F9B8-31CF-4D0D-9482-B2C87C825A69Q27490830-9CF35A89-22AF-4D42-9B96-38E00CC3FD5EQ27641213-019A5281-06BC-47B5-AE75-32B5AB75E3AD
P2860
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@ast
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@en
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@nl
type
label
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@ast
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@en
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@nl
prefLabel
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@ast
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@en
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@nl
P2093
P50
P921
P3181
P356
P1433
P1476
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
@en
P2093
Hyeryun Choe
John L Sullivan
Katherine Luzuriaga
Michael A Berne
Michael J Moore
Mohan Somasundaran
Natalya Vasilieva
Swee Kee Wong
Thomas C Greenough
P2888
P3181
P356
10.1038/NATURE02145
P407
P4510
P577
2003-11-27T00:00:00Z
P5875
P6179
1040468747